> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 2 Fentanyl Transdermal Systems Withdrawn
- URL: https://www.fdaweb.com/2-fentanyl-transdermal-systems-withdrawn/
- Published: 2019-11-18T12:00:00.000Z
- Updated: 2026-09-14T15:53:29.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145526

*Federal Register* notice: FDA has withdrawn ANDA approvals for two fentanyl transdermal systems held by Mayne Pharma Group and Actavis Laboratories. The drug products are both transdermal systems designed with a liquid reservoir. The companies have both requested withdrawal of their respective applications and have waived their opportunity for a hearing. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-11-18/pdf/2019-24922.pdf?ref=fdaweb.com).